FDAnews
www.fdanews.com/articles/176382-md-anderson-inks-deal-to-acquire-elektas-linear-accelerators

MD Anderson Inks Deal to Acquire Elekta’s Linear Accelerators

April 27, 2016

The University of Texas MD Anderson Cancer Center has entered an agreement to acquire Elekta’s Infinity linear accelerators, brachytherapy afterloaders and software and service for an undisclosed sum.

The deal also includes Elekta’s beam-shaping product — the Agility 160-leaf multi-leaf collimator — as well as four high-dose-rate branchytherapy afterloaders and Oncentra Brachy treatment planning.

The order will be finalized during Elekta’s fourth quarter. — Anisa Jibrell

 

View More Stories